A comparison of outcomes from a regional Mesothelioma MDT against the National Lung Cancer Audit (NLCA) Mesothelioma standards

Pleural and Mediastinal Malignancies Pub Date : 2018-09-15 DOI:10.1183/13993003.CONGRESS-2018.PA2889

Maryam Ahmed, J. Lyons, S. Jackson, A. Sharman, M. Dixon, P. Taylor, J. Holme, M. Evison

{"title":"A comparison of outcomes from a regional Mesothelioma MDT against the National Lung Cancer Audit (NLCA) Mesothelioma standards","authors":"Maryam Ahmed, J. Lyons, S. Jackson, A. Sharman, M. Dixon, P. Taylor, J. Holme, M. Evison","doi":"10.1183/13993003.CONGRESS-2018.PA2889","DOIUrl":null,"url":null,"abstract":"Background: Malignant mesothelioma (MM) is an incurable malignancy with a poor prognosis. In 2014, 43% of patients survived to one year following diagnosis in the UK. There is evidence of patient benefit from regional mesothelioma multidisciplinary team meetings1. The 2016 NLCA Pleural Mesothelioma report defined key recommendations for patients diagnosed with MM in England in 2014. Aims: To evaluate and compare outcomes of patients managed through the Greater Manchester Regional Mesothelioma MDT against the 2016 NLCA findings. Methods: Retrospective review of MM cases discussed at our MDT meeting between April 2016 and February 2018 using data from electronic MDT proformas. Results: Conclusions: Outcomes from our MDT are encouraging and may help build evidence in favour of regional mesothelioma MDTs. In particular, active treatment rates and ensuring equity of access to clinical research appears higher than national figures within this specialist service. References: 1. Bibby, Anna C et al. “What Is the Role of a Specialist Regional Mesothelioma Multidisciplinary Team Meeting? A Service Evaluation of One Tertiary Referral Centre in the UK.” BMJ Open 6.9 (2016): e012092.","PeriodicalId":20113,"journal":{"name":"Pleural and Mediastinal Malignancies","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2018-09-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pleural and Mediastinal Malignancies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1183/13993003.CONGRESS-2018.PA2889","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 1

Abstract

Background: Malignant mesothelioma (MM) is an incurable malignancy with a poor prognosis. In 2014, 43% of patients survived to one year following diagnosis in the UK. There is evidence of patient benefit from regional mesothelioma multidisciplinary team meetings1. The 2016 NLCA Pleural Mesothelioma report defined key recommendations for patients diagnosed with MM in England in 2014. Aims: To evaluate and compare outcomes of patients managed through the Greater Manchester Regional Mesothelioma MDT against the 2016 NLCA findings. Methods: Retrospective review of MM cases discussed at our MDT meeting between April 2016 and February 2018 using data from electronic MDT proformas. Results: Conclusions: Outcomes from our MDT are encouraging and may help build evidence in favour of regional mesothelioma MDTs. In particular, active treatment rates and ensuring equity of access to clinical research appears higher than national figures within this specialist service. References: 1. Bibby, Anna C et al. “What Is the Role of a Specialist Regional Mesothelioma Multidisciplinary Team Meeting? A Service Evaluation of One Tertiary Referral Centre in the UK.” BMJ Open 6.9 (2016): e012092.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

区域性间皮瘤MDT与国家肺癌审计(NLCA)间皮瘤标准结果的比较

背景:恶性间皮瘤(MM)是一种无法治愈的恶性肿瘤，预后不良。2014年，在英国，43%的患者在确诊后存活到一年。有证据表明，区域性间皮瘤多学科小组会议对患者有益。2016年NLCA胸膜间皮瘤报告确定了2014年英国诊断为MM的患者的关键建议。目的:评估和比较通过大曼彻斯特地区间皮瘤MDT治疗的患者的结果与2016年NLCA研究结果。方法:回顾性分析2016年4月至2018年2月MDT会议上讨论的MM病例，使用MDT电子表格的数据。结论:我们的MDT的结果是令人鼓舞的，可能有助于建立支持区域间皮瘤MDT的证据。特别是，在这一专业服务中，积极治疗率和确保公平获得临床研究似乎高于全国数字。引用:1。Bibby, Anna C等人，“区域间皮瘤多学科专家小组会议的作用是什么?”英国一家高等教育转诊中心的服务评估。BMJ Open 6.9 (2016): e012092。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Pleural and Mediastinal Malignancies

自引率

0.00%

发文量